Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E5TION: Prasugrel 5 mg vs Ticagrelor 60 mg in Complex High-Risk PCI Patients
KCT0004788Phase 4Recruiting
- Sponsor
- CG MedTech
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Prasugrel 5 mg with Ticagrelor 60 mg (2 arms). Started Dec 2019; status: recruiting.
02
Drugs
prasugrelticagrelor
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0004788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004788.